Brand Name: Viraday
Generic Name: Emtricitabine+Tenofovir disoproxil fumarate+Efavirenz
Manufacturer: Cipla
Dosage Form: Tablet
Strength: 200mg/300mg/600mg
Composition: Emtricitabine(200mg) + Tenofovir disoproxil fumarate(300mg) + Efavirenz(600mg)
Indication: HIV
Packaging: 30 tablets
Storage: Store at room temperature
Overview Of Viraday Tablet
Viraday (Emtricitabine + Tenofovir disoproxil fumarate + Efavirenz) tablet is a combination of three antiretroviral medications. It is used for the treatment of HIV (human immunodeficiency virus) infection. This medication belongs to a class of medication known as nucleoside reverse transcriptase inhibitors (NRTIs). Viraday tablet boosts your immune system to fight against infection and helps to reduce the amount of HIV in your body and improves the quality of life. It is important to take Viraday tablet as prescribed by your doctor. Do not take this medicine in the wrong way as it may lead to some serious side effects.
Pharmacodynamics
Emtricitabine (Viraday):- a synthetic nucleoside analog of cytidine, is phosphorylated by cellular enzymes to form emtricitabine 5′-triphosphate. It inhibits the activity of the HIV-1 reverse transcriptase (RT) by competing with the natural substrate deoxycytidine 5′-triphosphate and by being incorporated into nascent viral DNA which results in chain termination. Emtricitabine is a weak inhibitor of mammalian DNA polymerase alpha, beta, epsilon, and mitochondrial DNA polymerase gamma.
Tenofovir Disoproxil Fumarate (Viraday):- Tenofovir disoproxil fumarate is an acyclic nucleoside phosphonate diester analog of adenosine monophosphate. Tenofovir disoproxil fumarate requires initial diester hydrolysis for conversion to tenofovir and subsequent phosphorylations by cellular enzymes to form tenofovir diphosphate. It inhibits the activity of HIV-1 RT by competing with the natural substrate deoxyadenosine 5′-triphosphate and, after incorporation into DNA, by DNA chain termination.
Efavirenz (Viraday):- belongs to the NNRTI (non-nucleoside reverse transcriptase inhibitors) class of antiretrovirals. Both nucleoside and non-nucleoside RTIs inhibit the same target, the reverse transcriptase enzyme, an essential viral enzyme that transcribes viral RNA into DNA. Unlike nucleoside RTIs, which bind at the enzyme’s active site, NNRTIs act allosterically by binding to a distinct site away from the active site known as the NNRTI pocket.
Usage
Viraday tablet is a combination of three anti-HIV medicines: Emtricitabine, Tenofovir disoproxil fumarate, and Efavirenz. This medication is not a permanent cure for HIV infection. It only prevents the multiplication of HIV (human immunodeficiency virus) infection in human cells. The recommended dose of Viraday medicine is decided by a doctor according to your previous medical condition and response to the treatment. It is advisable not to change your regular dosing schedule without taking suggestions from your doctor. If you experience any signs and symptoms while receiving Viraday tablet, inform your doctor immediately.
Interactions
Viraday tablets can interact with other medications and it may increase the risk for side effects. Don’t forget to disclose and discuss your previous medical history with the doctor.
Medicine Interactions
Fluconazole
Gentamicin
Cisplatin
Amiodarone
Leflunomide
Aspirin
Azithromycin
Tobramycin
Ciprofloxacin
Disease Interactions
Renal dysfunction
Hepatic impairment
CNS disorders
Alcohol Interaction
Interaction with alcohol is unknown. Please consult your doctor before consuming alcohol.
Contraindication
Do not use this medicine if you are allergic to Emtricitabine, Tenofovir disoproxil fumarate, and Efavirenz
Viraday tablet is not recommended in patients known to be hypersensitive.
Alternate Brands
Teefavir
Teevir


